Phase 1 trial of immunological adjuvant QS-21 with a GM2 ganglioside-keyhole limpet haemocyanin conjugate vaccine in patients with malignant melanoma
(Q40694541)
scientific article published on November 1994
scientific article published on November 1994
Language:
Current Data About
Phase 1 trial of immunological adjuvant QS-21 with a GM2 ganglioside-keyhole limpet haemocyanin conjugate vaccine in patients with malignant melanoma
other details
description | scientific article published on November 1994 |
External Links
(P356) |
10.1016/S0264-410X(94)80052-2
|
(P698) |
7856291
|